Clinical trials · New York, NY
Scleroderma clinical trials in New York
We’re tracking 6 recruiting scleroderma studies with a site in or near New York — including Phase 1, Phase 2 and Phase 2/Phase 3 studies, each written for real people, not researchers.
Recruiting studies near New York
- NCT01776398Recruiting
Donating breath, blood, and urine samples for lung research
This study collects airway samples (usually during a bronchoscopy), plus blood and/or urine, to help researchers study lung conditions. It may help advance understanding of lung disease and related biology, but it is not a treatment trial.
New York, New YorkAges 18 years+ - NCT05878717RecruitingPhase 2/Phase 3
Belimumab for adults with scleroderma lung scarring
This Phase 2/3 study tests whether belimumab can improve outcomes and safety in adults with systemic sclerosis (scleroderma) that has caused lung scarring. It may help by reducing active or worsening immune-driven disease in the lungs.
New York, New YorkAges 18 years+ - NCT06195072RecruitingPhase 2
Platform study for scleroderma with lung disease
This trial tests new treatments for people with scleroderma-related lung disease. You may be eligible if you have systemic sclerosis with lung scarring, your symptoms started within the last 7 years, and you have not had certain prior treatments or transplants.
New York, New YorkAges 18 years+ - NCT01656447Recruiting
Scleroderma patient registry and tissue repository study
This study builds a registry of people with scleroderma and may store medical information and samples for future research. It can help researchers better understand the disease and develop better treatments.
New York, New YorkAges 18 years+ - NCT06328777RecruitingPhase 2/Phase 3
Testing a new immune cell therapy for systemic sclerosis (scleroderma)
This trial tests a new treatment called CABA-201, which uses your own immune cells to target and calm the overactive immune system causing scleroderma. It aims to reduce symptoms and slow or stop the disease's progression.
New York, New YorkAges 18–75 - NCT03816345RecruitingPhase 1
Nivolumab for advanced cancer with autoimmune disease
This trial tests whether the immunotherapy drug nivolumab can safely treat advanced cancer in people who also have an autoimmune disease like rheumatoid arthritis, lupus, or multiple sclerosis. It aims to find out if the drug may help control cancer while managing their autoimmune condition.
New York, New YorkAges 18 years+
Hear when a new Scleroderma trial opens near New York, NY
We’ll email you when one opens near New York, NY — at most once a week, no account needed, unsubscribe anytime.
Scleroderma trials in other cities
Where these studies are running near New York
Institutions with a site for the recruiting scleroderma studies listed above.
- Columbia University Irving Medical Center · 3 studies
- Hospital for Special Surgery · 2 studies
- GSK Investigational Site
- Northwell Health
- NYU Langone Health
- NYU Langone Hospital - Long Island
- Rutgers Cancer Institute of New Jersey
- Rutgers Robert Wood Johnson Medical School
What taking part in a scleroderma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting scleroderma studies in New York.
Common questions
- Are there scleroderma clinical trials near New York?
- Yes. We're currently tracking 6 recruiting scleroderma studies with a site near New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a scleroderma study near New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site near New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a scleroderma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New scleroderma studies open near New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.